Spontaneous recanalization in acute large core ischemic stroke due to large vessel occlusion: a post-hoc analysis of the ANGEL-ASPECT trial
- 27 September 2024
- journal article
- research article
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 18 (1) , 91-98
Abstract
Background Previous studies have indicated that a subset of patients with acute ischemic stroke (AIS) due to large vessel occlusion (LVO) experience spontaneous recanalization (SR), but the prognosis and factors associated with SR in these individuals are not well characterized. Methods We conducted a post hoc secondary analysis of the Study of Endovascular Therapy in Acute Anterior Circulation Large Vessel Occlusive Patients with a Large Infarct Core (ANGEL-ASPECT) trial. SR in the medical management group was defined as a modified arterial occlusive lesion (AOL) grade of 2 or 3 on computed tomography angiography (CTA) or magnetic resonance angiography (MRA) at 36 hours (±12 hours). Results SR was detected in 67 out of 184 patients (36.4%) in the medical management (MM) group. The median age of patients was 67 years (interquartile range (IQR) 58–72), and 48 (71.6%) were male. The adjusted odds ratio (aOR) for 90-day modified Rankin Scale (mRS) score shift toward better outcomes of the MM with SR group vs the MM without SR group was 1.83, with marginally significant difference (95% confidence interval (CI) 0.992 to 3.36; P=0.053). No significant difference was found between the MM with SR group and EVT recanalization group (aOR 1.45; 95% CI 0.86 to 2.43; P=0.16) with similar findings in the inverse probability treatment weighting analysis (OR 0.85; 95% CI 0.49 to 1.48; P=0.57). Multivariable regression analysis showed that hypertension, atherothrombotic stroke and higher clot burden score were factors associated with SR. Conclusions SR in medically managed patients with acute large ischemic stroke caused by LVO was associated with good functional outcome. An improved understanding of SR patients may be helpful to develop therapeutic strategy in patients with large infarct due to LVO in anterior circulation. Trial registration number NCT04551664.Keywords
This publication has 29 references indexed in Scilit:
- Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open-label, randomised trialThe Lancet, 2023
- Improved Prospects for Thrombectomy in Large Ischemic StrokeNew England Journal of Medicine, 2023
- Endovascular treatment versus no endovascular treatment after 6–24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands: a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trialThe Lancet, 2023
- Thrombectomy for Stroke in the Public Health Care System of BrazilNew England Journal of Medicine, 2020
- Endovascular Thrombectomy with or without Intravenous Alteplase in Acute StrokeNew England Journal of Medicine, 2020
- Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion ImagingNew England Journal of Medicine, 2018
- Predictive Factors for the Spontaneous Recanalization of Large and Middle Cerebral Arteries after Acute OcclusionJournal of Stroke and Cerebrovascular Diseases, 2016
- Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in StrokeNew England Journal of Medicine, 2015
- Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging SelectionNew England Journal of Medicine, 2015
- A Randomized Trial of Intraarterial Treatment for Acute Ischemic StrokeNew England Journal of Medicine, 2015